Literature DB >> 28379461

Current Practice Trends for Use of Early Venous Thromboembolism Prophylaxis After Intracerebral Hemorrhage.

Laurel J Cherian1, Eric E Smith2, Lee H Schwamm3, Gregg C Fonarow4, Phillip J Schulte5, Ying Xian5, Jingjing Wu5, Shyam K Prabhakaran6.   

Abstract

BACKGROUND: Venous thromboembolism (VTE) is common after intracerebral hemorrhage (ICH). Guidelines recommend early VTE prophylaxis.
OBJECTIVE: To determine characteristics associated with early chemoprophylaxis (CP) after ICH in the Get With The Guidelines-Stroke registry.
METHODS: In this observational cohort study, we identified patients with ICH between January 1, 2009 and September 30, 2013, who (1) were non-ambulatory and/or not comfort care measures by hospital day 2; (2) were not transferred to another acute care facility; and (3) had known VTE prophylaxis status at end of hospital day 2. Categories for VTE prophylaxis were as follows: (1) mechanical non-CP or (2) CP with or without mechanical prophylaxis. Early prophylaxis was defined as occurring by hospital day 2. Using multivariable logistic regression, we assessed patient, hospital, and geographic factors independently associated with early CP use.
RESULTS: Among 74 283 patients with ICH from 1358 hospitals, 5929 (7.9%) received early CP, 66 444 (89.4%) received early mechanical/non-CP, and 1910 (2.6%) had no prophylaxis, mechanical or CP, within the first 2 days. There was no increase in early CP use over the study period; 60% of hospitals provided early CP to <9% of patients. In multivariable analysis, female sex, atrial fibrillation, diabetes, coronary, carotid, and peripheral artery disease, prior ischemic stroke or transient ischemic attack, hospital size >500 beds, and geographic region were independently associated with early vs no early CP use.
CONCLUSION: Nationwide, the large majority of ICH patients receive early mechanical VTE prophylaxis only, without CP. Patient comorbidities and hospital characteristics such as geographic location are determinants of higher use of early CP.
Copyright © 2017 by the Congress of Neurological Surgeons

Entities:  

Keywords:  Anticoagulants; Intracranial hemorrhage; Prevention and control; Pulmonary embolism; Venous thrombosis

Mesh:

Substances:

Year:  2018        PMID: 28379461     DOI: 10.1093/neuros/nyx146

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  3 in total

1.  Comparing pharmacological venous thromboembolism prophylaxis to intermittent pneumatic compression in acute intracerebral haemorrhage: protocol for a systematic review and network meta-analysis.

Authors:  Vignan Yogendrakumar; Ronda Lun; Brian Hutton; Dean A Fergusson; Dar Dowlatshahi
Journal:  BMJ Open       Date:  2018-11-05       Impact factor: 2.692

Review 2.  Anticoagulant management by low-dose of low molecular weight heparin in patients with nonvalvular atrial fibrillation following hemorrhagic transformation and complicated with venous thrombosis: Five case reports and literature review.

Authors:  Ling Zhang; Yu-Han Kong; Da-Wu Wang; Kai-Ting Li; He-Ping Yu
Journal:  Medicine (Baltimore)       Date:  2021-02-19       Impact factor: 1.817

3.  Venous Thromboembolism in ICU Patients with Intracerebral Hemorrhage: Risk Factors and the Prognosis After Anticoagulation Therapy.

Authors:  Quanhong Chu; Lin Liao; Wenxin Wei; Ziming Ye; Li Zeng; Chao Qin; Yanyan Tang
Journal:  Int J Gen Med       Date:  2021-09-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.